EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease

Ting Wang, Akira Sobue, Seiji Watanabe, Okiru Komine, Takaomi C Saido, Takashi Saito, Koji Yamanaka

Journal of Neuroinflammation · 21.02.2024 · 21 (1)

DOI: 10.1186/s12974-024-03046-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroinflammation, online erschienen am 21.02.2024. Verfasst von Ting Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Aichi, 464-8601, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moonshot R&D from Japan Science and Technology Agency, AMED, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuroinflammation substantially contributes to the pathology of Alzheimer’s disease (AD), the most common form of dementia. Studies have reported that nuclear factor erythroid 2-related factor 2 (Nrf2) attenuates neuroinflammation in the mouse models of neurodegenerative diseases, however, the detailed mechanism remains unclear.

Methods

The effects of dimethyl fumarate (DMF), a clinically used drug to activate the Nrf2 pathway, on neuroinflammation were analyzed in primary astrocytes and App NL−G−F ( App -KI) mice. The cognitive function and behavior of DMF-administrated App -KI mice were evaluated. For the gene expression analysis, microglia and astrocytes were directly isolated from the mouse cerebral cortex by magnetic-activated cell sorting, followed by quantitative PCR.

Results

DMF treatment activated some Nrf2 target genes and inhibited the expression of proinflammatory markers in primary astrocytes. Moreover, chronic oral administration of DMF attenuated neuroinflammation, particularly in astrocytes, and reversed cognitive dysfunction presumably by activating the Nrf2-dependent pathway in App -KI mice. Furthermore, DMF administration inhibited the expression of STAT3/C3 and C3 receptor in astrocytes and microglia isolated from App -KI mice, respectively, suggesting that the astrocyte–microglia crosstalk is involved in neuroinflammation in mice with AD.

Conclusion

The activation of astrocytic Nrf2 signaling confers neuroprotection in mice with AD by controlling neuroinflammation, particularly by regulating astrocytic C3-STAT3 signaling. Furthermore, our study has implications for the repositioning of DMF as a drug for AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionMiceAnimalsDimethyl FumarateMice, TransgenicNeuroinflammatory DiseasesNF-E2-Related Factor 2Disease Models, Animal

Stichwörter der Autor:innen

Alzheimer’s diseaseAstrocytesDimethyl fumarateNeuroinflammationNrf2STAT3

Substanzen

Dimethyl FumarateNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Aichi, 464-8601, Japan.
  • Department of Neuroscience and Pathobiology, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Aichi, 464-8601, Japan. a-sobue@riem.nagoya-u.ac.jp.
  • Medical Interactive Research and Academia Industry Collaboration Center, Research Institute of Environmental Medicine, Nagoya University, Aichi, Japan. a-sobue@riem.nagoya-u.ac.jp.
  • Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Saitama, Japan.
  • Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.

Förderung

  • Moonshot R&D from Japan Science and Technology Agency
  • AMED, Japan

Zitieren

APA

Wang, T., Sobue, A., Watanabe, S., Komine, O., Saido, T. C., Saito, T., & Yamanaka, K. (2024). Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease. Journal of Neuroinflammation, 21(1). https://doi.org/10.1186/s12974-024-03046-2

Vancouver

Wang T, Sobue A, Watanabe S, Komine O, Saido TC, Saito T, et al. Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease. Journal of Neuroinflammation. 2024;21(1). doi:10.1186/s12974-024-03046-2

BibTeX
@article{Wang2024,
  author = {Wang, Ting and Sobue, Akira and Watanabe, Seiji and Komine, Okiru and Saido, Takaomi C and Saito, Takashi and Yamanaka, Koji},
  title = {Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease},
  journal = {Journal of Neuroinflammation},
  year = {2024},
  volume = {21},
  number = {1},
  doi = {10.1186/s12974-024-03046-2}
}
Kostenlos starten →